Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials
- PMID: 10568904
- DOI: 10.1191/096120399680411362
Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials
Abstract
Discordance between patient and physician assessment of lupus activity occurs frequently and its determinants are not known. Examples of discordance between patients and physicians in other disease models can be found in the literature. A better understanding of the discordance between patients and physicians can help us achieve a shared decision-making model of health care, improve patient satisfaction, improve patient compliance, and improve physician understanding of how lupus impacts on their patients. Understanding discordance also impacts on the design and interpretation of clinical trials.
Similar articles
-
Determinants of discordance between patients and physicians in their assessment of lupus disease activity.J Rheumatol. 2003 Sep;30(9):1967-76. J Rheumatol. 2003. PMID: 12966600
-
Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.J Rheumatol. 2000 Mar;27(3):675-9. J Rheumatol. 2000. PMID: 10743807
-
Discordant assessment of lupus activity between patients and their physicians: the Singapore experience.Lupus. 2010 Jan;19(1):100-6. doi: 10.1177/0961203309345748. Epub 2009 Oct 30. Lupus. 2010. PMID: 19880553
-
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus.Best Pract Res Clin Rheumatol. 2023 Dec;37(4):101939. doi: 10.1016/j.berh.2024.101939. Epub 2024 Mar 14. Best Pract Res Clin Rheumatol. 2023. PMID: 38485601 Review.
-
Caring for the adolescent with systemic lupus erythematosus.Adolesc Med. 1998 Feb;9(1):59-67, vi. Adolesc Med. 1998. PMID: 10961252 Review.
Cited by
-
The Lived Experience of Lupus Flares: Features, Triggers, and Management in an Australian Female Cohort.Int J Chronic Dis. 2014;2014:816729. doi: 10.1155/2014/816729. Epub 2014 Nov 20. Int J Chronic Dis. 2014. PMID: 26464865 Free PMC article.
-
EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.Front Med (Lausanne). 2022 Dec 20;9:1092325. doi: 10.3389/fmed.2022.1092325. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36606059 Free PMC article.
-
Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity.Health Qual Life Outcomes. 2019 Jun 7;17(1):99. doi: 10.1186/s12955-019-1151-8. Health Qual Life Outcomes. 2019. PMID: 31174541 Free PMC article.
-
Patient-Reported Outcomes in Systemic Lupus Erythematosus.Rheum Dis Clin North Am. 2016 May;42(2):253-263. doi: 10.1016/j.rdc.2016.01.001. Epub 2016 Mar 17. Rheum Dis Clin North Am. 2016. PMID: 27133488 Free PMC article. Review.
-
The NYMERIA Study: A Real-World, Multicentre Contemporary Assessment of Disease- and Patient-Related Burden and Treatment Strategies in Patients with Systemic Lupus Erythematosus.Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):392-401. doi: 10.31138/mjr.160524.tns. eCollection 2024 Jun. Mediterr J Rheumatol. 2024. PMID: 39193181 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical